0

Journal Articles

in Drug Prescribing Behavior
 1-20 of 81 Articles
Medical News and Perspectives |  April 17, 2013
“Nightmare” Bacteria on the Rise in US Hospitals, Long-term Care Facilities
Bridget M. Kuehn, MSJ
JAMA. 2013;309(15):1573-1574. doi:10.1001/jama.2013.2922.
Care of the Aging Patient: From Evidence to Action |  April 03, 2013
Management of Human Immunodeficiency Virus Infection in Advanced Age
Meredith Greene, MD; Amy C. Justice, MD, PhD; Harry W. Lampiris, MD; et al.
JAMA. 2013;309(13):1397-1405. doi:10.1001/jama.2013.2963.
INCLUDES: , Supplemental Content
JAMA Patient Page |  April 03, 2013 FREE
Statins
Deborah Tolmach Sugerman, MSW; Edward H. Livingston, MD; Cassio Lynm, MA
JAMA. 2013;309(13):1419. doi:10.1001/jama.2013.3041.
INCLUDES: , Supplemental Content
Viewpoint |  March 06, 2013
Improving Opioid Prescribing:  The New York City Recommendations
David N. Juurlink, MD, PhD; Irfan A. Dhalla, MD, MSc; Lewis S. Nelson, MD
JAMA. 2013;309(9):879-880. doi:10.1001/jama.2013.1139.
Clinical Crossroads |  March 06, 2013
Chronic Back Pain With Possible Prescription Opioid Misuse
Daniel P. Alford, MD, MPH
JAMA. 2013;309(9):919-925. doi:10.1001/jama.2013.522.
INCLUDES: CME
JAMA Clinical Evidence Synopsis |  February 20, 2013
Clinical Outcomes Associated With Procalcitonin Algorithms to Guide Antibiotic Therapy in Respiratory Tract Infections
Philipp Schuetz, MD, MPH; Matthias Briel, MD, MSc; Beat Mueller, MD
JAMA. 2013;309(7):717-718. doi:10.1001/jama.2013.697.
Research Letters |  February 20, 2013
Pharmaceutical Overdose Deaths, United States, 2010
Christopher M. Jones, PharmD; Karin A. Mack, PhD; Leonard J. Paulozzi, MD
JAMA. 2013;309(7):657-659. doi:10.1001/jama.2013.272.
From the Centers for Disease Control and Prevention |  February 13, 2013
Buprenorphine Prescribing Practices and Exposures Reported to a Poison Center—Utah, 2002-2011
JAMA. 2013;309(6):536-538. doi:10.1001/jama.2012.217206.
Viewpoint |  February 06, 2013
FDA Regulation of Off-label Drug Promotion Under Attack
Aaron S. Kesselheim, MD, JD, MPH; Michelle M. Mello, JD, PhD, MPhil; Jerry Avorn, MD
JAMA. 2013;309(5):445-446. doi:10.1001/jama.2012.207972.
Research Letters |  December 05, 2012
Routine Conflict of Interest Disclosure by Preclinical Lecturers and Medical Students' Attitudes Toward the Pharmaceutical and Device Industries
Azalea Kim, MPA; Lawrence A. Mumm, BA; Deborah Korenstein, MD
JAMA. 2012;308(21):2187-2189. doi:10.1001/jama.2012.25315.
Viewpoint |  November 14, 2012
Rethinking Opioid Prescribing to Protect Patient Safety and Public Health
G. Caleb Alexander, MD, MS; Stefan P. Kruszewski, MD; Daniel W. Webster, ScD, MPH
JAMA. 2012;308(18):1865-1866. doi:10.1001/jama.2012.14282.
Viewpoint |  October 10, 2012
The FDA Safety and Innovation Act
Robert Steinbrook, MD; Joshua M. Sharfstein, MD
JAMA. 2012;308(14):1437-1438. doi:10.1001/jama.2012.12829.
Medical News and Perspectives |  October 03, 2012
IDSA: Avoid Antibiotics for Most Throat Infections
Bridget M. Kuehn
JAMA. 2012;308(13):1307. doi:10.1001/jama.2012.13019.
Research Letters |  September 12, 2012 FREE
Changes in Direct-to-Consumer Pharmaceutical Advertising Following Shifts From Prescription-Only to Over-the-Counter Status
Jeremy A. Greene, MD, PhD; Niteesh K. Choudhry, MD, PhD; Aaron S. Kesselheim, MD, JD, MPH; et al.
JAMA. 2012;308(10):973-975. doi:10.1001/2012.jama.10647.
Medical News and Perspectives |  September 05, 2012
European Drug Agency Works to Improve Transparency, but Skepticism Remains
Tracy Hampton, PhD
JAMA. 2012;308(9):850-851. doi:10.1001/2012.jama.10451.
Viewpoint |  August 01, 2012
Curbing the Opioid Epidemic in the United States:  The Risk Evaluation and Mitigation Strategy (REMS)
Lewis S. Nelson, MD; Jeanmarie Perrone, MD
JAMA. 2012;308(5):457-458. doi:10.1001/jama.2012.8165.
Medical News and Perspectives |  March 07, 2012
Effects of FDA Safety Warnings May Vary
Bridget M. Kuehn
JAMA. 2012;307(9):894-895. doi:10.1001/jama.2012.217.
From the Centers for Disease Control and Prevention |  December 14, 2011 FREE
QuickStats: Percentage of Adults Aged 18-64 Years Who Did Not Get Needed Prescription Drugs Because of Cost,* by Poverty Status†—National Health Interview Survey, United States, 1999-2010§
JAMA. 2011;306(22):2452. doi:.
Research Letters |  April 06, 2011 FREE
Characteristics of Opioid Prescriptions in 2009
Nora D. Volkow, MD; Thomas A. McLellan, PhD; Jessica H. Cotto, MPH; et al.
JAMA. 2011;305(13):1299-1301. doi:10.1001/jama.2011.401.
Medical News & Perspectives |  March 16, 2011
New “Law” Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing
Mike Mitka
JAMA. 2011;305(11):1083-1084. doi:10.1001/jama.2011.285.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 13, 2013
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Trends in On-label and Off-label Modafinil Use in a Nationally Representative Sample
Renée A. Peñaloza, MS; Urmimala Sarkar, MD, MPH; David M. Claman, MD; et al.
JAMA Internal Medicine
Original Investigation  |  March 18, 2013
Prolonged Antibiotic Treatment in Long-term Care:  Role of the Prescriber
Nick Daneman, MD, MSc; Andrea Gruneir, PhD; Susan E. Bronskill, PhD; et al.
JAMA Internal Medicine
Invited Commentary  |  March 18, 2013
Improving Prescribing of Antibiotics in Long-term Care:  Comment on “Prolonged Antibiotic Treatment in Long-term Care”
Carmel M. Hughes, PhD; Michael M. Tunney, PhD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems